sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global HIV Vaccine Market Research Report - Forecast to 2027

Global HIV Vaccine Market Research Report - Forecast to 2027

Home / Categories / Healthcare
Global HIV Vaccine Market Research Report - Forecast to 2027
Global HIV Vaccine Market Research...
Report Code
RO1/111/1042

Publish Date
13/Nov/2016

Pages
52
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Table of Contents:

1 Report Prologue
2 Introduction
2.1 DEFINITION
2.2 SCOPE OF STUDY:
2.2.1 RESEARCH OBJECTIVE
2.3 ASSUMPTIONS & LIMITATIONS
2.3.1 ASSUMPTIONS
2.3.2 LIMITATIONS
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising R&D Funding for HIV Vaccine
4.2.2 Rising prevalence of HIV due to Prostitution
4.2.3 Increasing awareness due to HIV prevention programs
4.2.4 Growing number of new entrants in the market
4.3 Restraints
4.3.1 HIV vaccine Approvals
4.4 Challenges
4.4.1 Lack of natural immunity to HIV
4.4.2 Variability of HIV types
4.4.3 Animal model trials
5 Market Factor Analysis
5.1 Investment Opportunity Analysis
6 Global HIV Vaccine Market, By clinical Trials
6.1 Introduction
6.1.1 Phase I
6.1.2 Phase II
6.1.3 Phase III
7 Global HIV Vaccine Market, By Region
7.1 Introduction
7.2 North America
7.3 Europe
7.4 Asia Pacific
8 Competitive Landscape
8.1 Introduction
8.1.1 Collaboration
8.1.2 Acquisition
8.1.3 Agreement
8.1.4 Partnership
9 COMPANY PROFILE
9.1 Argos Therapeutics, Inc.
9.1.1 Company Overview
9.1.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.1.3 Financials
9.1.4 Key Developments
9.2 Bionor Pharma ASA
9.2.1 Company Overview
9.2.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.2.3 Financials
9.2.4 Key Developments
9.3 Janssen Global Services, LLC
9.3.1 Company Overview
9.3.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.3.3 Financials
9.3.4 Key Developments
9.4 GENECURE LLC
9.4.1 Company Overview
9.4.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.4.3 Financials
9.4.4 Key Developments
9.5 GeoVax
9.5.1 Company Overview
9.5.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.5.3 Financials
9.5.4 Key Developments
9.6 GENVEC, INC.
9.6.1 Company Overview
9.6.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.6.3 Financials
9.6.4 Key Developments
9.7 PaxVax Corporation
9.7.1 Company Overview
9.7.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.7.3 Financials
9.7.4 Key Developments
9.8 Inovio Pharmaceuticals, Inc.
9.8.1 Company Overview
9.8.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.8.3 Financials
9.8.4 Key Developments
9.9 GlaxoSmithKline plc
9.9.1 Overview
9.9.2 Product overview
9.9.3 Financials
9.9.4 Key Developments
9.1 SANOFI
9.10.1 COMPANY OVERVIEW
9.10.2 PRODUCT OVERVIEW
9.10.3 FINANCIALS
9.10.4 Key Developments
10 APPENDIX
10.1 DISCUSSION BLUE PRINT

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com